U.S. Markets open in 52 mins.

ZIOPHARM Oncology, Inc. (ZIOP)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
5.34-0.17 (-3.09%)
At close: 4:00PM EDT
People also watch
XONHALOCLDXJUNOFOLD
  • G
    George
    George
    Its very educational to watch the former Used Car Salesman turned self-proclaimed "Pharmamaven" continue to change his ZIOP investment thesis in an effort to explain away the company's struggling research programs and failed rented technologies.
  • G
    George
    George
    ZIOP Pumper KIng, Rob_Cos, - Style "Deep Diving Due Diligence" Resulting in Cerebral Hypoxia and Hallucinations Involving ZIOP Buyouts.

    Please enjoy this unintentional yet classic humor from Wrong-Way Rob_Cos and his Perpetually Imminent ZIOP Buyout Nonsense.

    rob_cos • Oct 15, 2015 9:42 AM 
Kirk told U he is selling ZIOP-expect a takeover P/R soon!!!!!

    conrbrt1970 • Oct 15, 2015 10:33 AM 
So you posted this for two days in a row now. Why the repeat?

    rob_cos • Oct 16, 2015 11:25 AM
 Because its now been confirmed XON's Kirk went to EU last minute in a top secret trip this week!!!!

    conrbrt1970 • Oct 16, 2015 12:45 PM
 There is just nothing better than a "top secret" trip to get the blood pumping. Wait, how top secret can it be if people are posting about it on a yahoo board? You sure he isn't on double secret probation right? Where's Neidermeyer when you need him?!?!

    
belgiantrollhater • Oct 16, 2015 1:05 PM
 Ok, I'll bite.
Confirmed by who?
I would love to buy more and would if I had some confirmation of a top secret trip.


    rob_cos • Oct 19, 2015 11:31 AM 
Here is what Kirk said about selling ZIOP...word is sudden trip to EU last week. SOON!!!!!!

    racheleschneider14 • Oct 20, 2015 8:41 AM 
Keep pumping Rob.......as you can see it's not helping the stock price. No one will buy this company until they have some products in phase 2/3 trials and that's not going to be for some time. So please stop with the bo rumour and concentrate on the science.

    

conrbrt1970 • Oct 20, 2015 9:39 AM 
That's all well in good... but his posts from the last week have all been on information that is months old. And he repeats the same drum beat over and over and over again on multiple boards, not just this one. So why? I'm long, and would love to see a buy out, or the stock to just go up... how about that for a novel idea!

    
luckijack1 • Oct 20, 2015 12:52 PM 
rob_cos is looking desperate. I'm long on this stock, but rehashing old stuff and trying to make it look new...….jack

    
conrbrt1970 • Oct 19, 2015 1:26 PM 
You really are desperate! I just did a quick search... "Kirk on ZIOP acquisition" and funny the comments that turn up.. They are all from someone named Rob_Cos... InvestorVillage, Twitter and more... You have been pumping the same info

    Wrong-Way Rob_Cos, always reposting his "lists" that in his mind provide support for his Perpetually Imminent ZIOP Buyout that has being ongoing for well over TWO YEARS now. Is anyone actually still buying into his incessant ZIOP pumping?
  • W
    Walter
    Walter
    ZamDopey - Look at this baby drop! WOW! How soon before it's below $5 HopeyDopey? It should be in the $4 range before fall.
    Imagejustalittletumblweed
  • Z
    ZAMD549
    ZAMD549
    Man this board & that Village Board are going downhill fast huh? If these 24/7 goon bashers are so smart, how come they don't TELL THEIR REAL NAMES LIKE THAT ROB DUDE, versus being anonymous cowards? Am I right? Of course I am!
  • W
    William
    William
    Favorite SMD by Motley Stool.
  • Z
    ZAMD549
    ZAMD549
    Hey George, I have not been here forever, but I see that you are still your sick obsessed self, missing and loving on Robbie....LOL! Hey, didn't you also pump up BLCM? I see it is down 24% now. And you pump up CLLS, a #$%$ Parisian company that ZIOP will fly past soon I bet.
  • E
    ExperiencedBIoPharmGuy
    ExperiencedBIoPharmGuy
    Devastating PR: ZIOP still selling futures.
  • C
    Crecy
    Crecy
    AVEO ...Tivozanib (Advanced Renal Cancer) Approval date n EU end of Aug.
  • B
    BermudaG
    BermudaG
    prepare for it again,, ziop at 5.75 market cap of 800 mill ??? gotta be kidding ... easily retests 52 week low.. glta and congrats to dvax holders !
  • G
    George
    George
    In case you missed it: CLLS continues to impress with additional CRISPR intellectual property for use in gene-edited T-Cell technology.
  • D
    Den
    Den

    Found a great no fee daytrading newsletter, vist www.PennySt0ckl0l.org and sign up...so glad I did

  • A
    Andrew
    Andrew

    https://www.statnews.com/2017/08/03/ziopharm-fda-brain-cancer/?s_campaign=stat:rss&utm_source=STAT+Newsletters&utm_campaign=308651db62-STAT_Plus&utm_medium=email&utm_term=0_8cab1d7961-308651db62-150056661

    Ziopharm: what's going on with their phase 3 brain cancer trials?
    Four months after Ziopharm Oncology said FDA gave “positive guidance” on the design of a phase 3 clinical trial for brain cancer, it has offered no details.
    www.statnews.com
  • G
    George
    George

    Kite Highlights Durable Complete Remissions Up to 56+ Months in Patients with Chemorefractory Aggressive Non-Hodgkin Lymphoma (NHL) after Anti-CD19 CAR T-Cell Therapy at the National Cancer Institute.

    http://www.businesswire.com/news/home/20170720005353/en/

  • P
    Pharmaherooooooo
    Pharmaherooooooo

    KTOV = Mcap $16 Mil /Cash $17 Mil / ULTRA Low float O/S 10.6 M / NDA submission for potential Blockbuster this Quarter = 20 BAGGER ..ONE OF THE BIGGEST BIOTECH OPPORTUNITY EVER ! Thank me later guys

    Kitov Pharma (KTOV)

    Market Cap: $17 M
    Cash $17 M
    Price: $1.50

    Shares Out: 10.6 Million

    Kitov Pharmaceuticals Initiates NDA Filing for KIT-302 as a Treatment for Osteoarthritis and Hypertension
    https://baystreet.ca/articles/research_reports/lifesci/Kitov062717.pdf

    Kitov Expects to Submit an NDA for KIT-302 in the Third Quarter 2017.Kitov announced that it began the process of compiling the documents necessary to file an NDA for its lead asset KIT-302 as a treatment for patients who experience both osteoarthritis and hypertension. The Company hired Parexel International Corporation, a clinical research organization, to digitalize and formally submit its NDA application. Kitov expects the filing to occur during the third quarter of 2017, with a potential FDA approval during the second quarter of 2018.

    KIT-302 is a combination drug that treats osteoarthritis pain and hypertension simultaneously

    Primary efficacy endpoint achieved Lead drug candidate KIT-302 achieved its primary efficacy endpoint in a pivotal Phase III trial

    Marketing potential Pipeline candidates address large, multi-billion dollar markets

    “KIT-302 has the potential to address the multi-billion dollar market for the treatment of osteoarthritis pain and hypertension with one drug that reduces patients’ risk of suffering a heart attack or stroke, while also reducing cost for payers. There is currently no single medication on the market that treats both osteoarthritis pain and hypertension and thus, KIT-302 will be the only NSAID indicated both to treat pain and to reduce the risk of heart attack, stroke and death.”

    Pain medications for osteoarthritis account for billions of dollars in annual sales globally. Most pain medications for osteoarthritis, including celecoxib which had global sales of $2.7 billion in 2014, are non-steroidal anti-inflammatory drugs (NSAIDs) which have the side effect of elevating blood pressure, and increasing the risk of heart attacks, strokes and death. Of the 27 million Americans who live with osteoarthritis, 13.5 million also suffer from hypertension, which also increases the risk of heart attack, stroke, and death.

  • A
    AntonI
    AntonI
    Newbie here. So, can I hear some intelligent comments as to why this treatment is superior to the Northwest Bio's (NWBO) DCVax (currently in phase 3 that is almost completed)? Thanks.
  • Z
    ZAMD549
    ZAMD549
    Large Jan $10 call buyer, over 3K; very bold; if just a hedge, why so far out in time? They could have obtained the Oct $10 calls for ONE THIRD THE PRICE of those bought in January. Very interesting.
  • A
    Alex Maynez
    Alex Maynez
    Entire sector down. Perfect buying prices.
  • Z
    ZAMD549
    ZAMD549
    The Rob obsession by George continues......LOL! Many on here don't even know who that is, but I bet you that he is no analyst, & probably not sold a car in decades (if he ever did that); don't get George's motivation, except that he is mad at Rob....did Rob make his investment bad or what? For all the time & money he spent attacking that dude, he could have bought a new boat or something huh? So ignorant, and it does not make anyone else sell here, since most are not so stupid. The stock is down cause "all" nearly biotech is down today, and it's on super low volume.....both ZIOP & XON have nearly exact volume - just noticed that. But obviously George will never ever get a life & never tell you his picks ahead of time.....lol.
  • Z
    ZAMD549
    ZAMD549
    So many better names in bio land to short & these obsessed mongrels keep trying on Ziopharm, even though less than a buck off of its lows; can you believe? So damn dumb!
  • B
    BermudaG
    BermudaG
    at $6 per share zip is valued at 800 mill ??? with only 80 mill in bank ?

    prepare for another offering eoy.. and yes still at $5 ish ..